Antibody-dependent cell-mediated cytotoxicity using monoclonal antibodies reacting with CEA. 1983

K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
February 1998, Journal of gastroenterology and hepatology,
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
April 1985, Cancer research,
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
January 2012, Oncoimmunology,
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
July 1990, Neurosurgery,
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
September 1986, Tissue antigens,
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
May 1985, Journal of immunology (Baltimore, Md. : 1950),
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
February 1990, Journal of clinical & laboratory immunology,
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
March 1997, Nihon rinsho. Japanese journal of clinical medicine,
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
December 2005, Cancer metastasis reviews,
K Imai, and T Sasanami, and H Fujita, and Y Moriya, and M Tsujisaki, and M Kawaharada, and S Ferrone, and A Yachi
February 1987, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!